NCT00943657

Yearly Strain Variation Study, 2009/2010

An Open-Label Phase 3 Study to Assess the Immunogenicity and Safety of a Vero Cell-Derived Trivalent Seasonal Influenza Vaccine, Strain Composition 2009/2010, in an Adult and Elderly Population

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 110 (estimated)
• Sponsor: Alachua Government Services, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to verify the immunogenicity and tolerance of a trivalent seasonal influenza vaccine with strain composition according to World Heath Organization/European Union (WHO/EU) recommendation for the 2009/2010 season for yearly licensing application.

Conditions

• Influenza
• Seasonal Influenza

Interventions

Type	Name	Description
BIOLOGICAL	Preflucel [Trivalent seasonal influenza vaccine (split virus, Vero cell-derived)]	Single intramuscular injection of vaccine

Timeline

• Start date: 2009-06-01
• Primary completion: 2009-07-01
• Completion: 2009-07-01
• First posted: 2009-07-22
• Last updated: 2015-10-09

Locations

1 site across 1 country: Austria